Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28.75 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $28.75 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $28.75 | 3 | Genentech USA, Inc. ($28.75) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Virology & Specialty Care | ||||||
| 03/02/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Virology & Specialty Care | ||||||
| 02/03/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 353 | 369 | $50,168 | $17,914 |
| 2022 | 12 | 472 | 496 | $72,284 | $28,109 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 96 | $13,205 | $5,559 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 66 | $13,378 | $4,571 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,638 | $2,919 | 30.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $7,979 | $2,259 | 28.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 31 | 31 | $2,015 | $1,257 | 62.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,329 | $513.42 | 38.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $840.00 | $389.28 | 46.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $330.00 | $178.20 | 54.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $387.60 | $111.72 | 28.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 17 | $364.44 | $99.67 | 27.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 26 | $702.00 | $57.20 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 103 | $14,200 | $6,473 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 77 | $15,608 | $6,395 | 41.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $11,048 | $3,893 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $10,881 | $3,648 | 33.5% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2022 | 22 | 22 | $10,142 | $3,088 | 30.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 53 | 53 | $3,445 | $2,164 | 62.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 20 | 40 | $1,400 | $653.34 | 46.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,246 | $554.75 | 44.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 13 | 13 | $1,845 | $494.66 | 26.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 22 | 22 | $899.36 | $417.81 | 46.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 33 | 33 | $786.78 | $264.25 | 33.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 29 | 29 | $783.00 | $64.12 | 8.2% |
About Gregory Peters
Gregory Peters is a Family healthcare provider based in Douglassville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2021. The National Provider Identifier (NPI) number assigned to this provider is 1720746381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gregory Peters has received a total of $28.75 in payments from pharmaceutical and medical device companies, with $28.75 received in 2022. These payments were reported across 3 transactions from 1 company. The most common payment nature is "Food and Beverage" ($28.75).
As a Medicare-enrolled provider, Peters has provided services to 825 Medicare beneficiaries, totaling 865 services with total Medicare billing of $46,024. Data is available for 2 years (2022–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Douglassville, PA
- Active Since 12/01/2021
- Last Updated 12/01/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1720746381
Products in Payments
- Xofluza (Drug) $28.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.